2017 American Transplant Congress

Monday, May 1, 2017

5:18pm-5:30pm

Donor-Specific B Cell Responses: Predicting the Future of Kidney Transplants.

M. Cascalho,¹ E. Farkash,² L. Adam,¹ M. Samaniego,³ J. Platt.

Concurrent Session: B Cells and Antibody in Rejection  •  E350

5:18pm-5:30pm

High Mortality in Transplant Recipients Associated with Coccidioidomycosis Derived from Organ Donors.

N. Jeyakumar,² N. Neidlinger,³ M. Salvatore,³ C. Brown,⁴ T. Carpenter,³ M. Fung,¹ P. Chin-Hong.¹

Concurrent Session: Infectious Pot-Pourri  •  E265

5:18pm-5:30pm

Living Kidney Donor Pharmaceutical Care Needs Identified Through Linked Transplant Registry and Pharmacy Claims Data.

K. Lentine,¹ S. Gustafson,² M. Schnitzler,¹ G. Hess,³ D. Segev,⁴ A. Garg,⁵ N. Lam,⁶ D. Axelrod,⁷ D. Brennan,⁸ H. Randall,¹ B. Kasiske.⁹

Concurrent Session: Logistic and Programatic Challenges in Kidney Living Donation  •  E450b

5:18pm-5:30pm

Outcomes with Kidney Transplant from Deceased Donors with Acute Kidney Injury and Prolonged Cold Ischemia Time: UNOS Analysis.

G. Dube, S. Mohan, M. Chiles.

Concurrent Session: Donors with Acute Kidney Injury  •  E450a

5:18pm-5:30pm

P-LKDPI: A Donor Risk Index for Pediatric Recipients of Living Donor Kidney Transplantation.

A. Massie, N. Desai, A. Neu, D. Segev.

Concurrent Session: Kidney: Pediatric Adherence and Allocation  •  E353B

5:18pm-5:30pm

Podocyte Participates in the ST2 Related Renal Fibrosis.

Y. Kim,¹ S. Yang,^2,3 R. Cha,⁴ M.-Y. Yu,¹ S. Lee,³ H. Lee,¹ J. Lee,⁵ D. Kim,^1,3 S. Kim,³ Y. Kim.^1,2,3

Concurrent Session: Basic Chronic Rejection  •  E351

5:18pm-5:30pm

The Associations Between Body Mass Index and Kidney Transplant Outcomes Are Mediated by Weight-Adjusted Immunosuppression Dosing.

K. Flabouris,^1,2 S. Chadban,^1,3,4 M. Ladhani,^1,3,5 M. Cervelli,⁶ P. Clayton.^1,2,6

Concurrent Session: Kidney: Cardiovascular and Metabolic  •  E451b

5:18pm-5:30pm

The Natural History of Kidney Rejection: How Do Molecular Disease States Change Over Time in Patients with Repeat Indication Biopsies?

J. Reeve, P. Halloran.

Concurrent Session: Antibody Mediated Rejection in Kidney Transplant Recipients: Pathophsiology and Epidimiology  •  E354a

5:18pm-5:30pm

Utility of IL-2 Complexes in Promoting Vascularized Composite Allograft Survival.

H. Xu,¹ S. Dahiya,² L. Wang,² T. Akimova,² W. Hancock,^2,4 S. Levin.³

Concurrent Session: Regulatory Cells in Alloimmunity  •  E352

5:18pm-5:30pm

VO_2peak: A Significant Marker of All-Cause Mortality Among Patients with End-Stage Renal Disease Being Evaluated for Kidney Transplant.

H. Chakkera,¹ M. Temkit,¹ B. Kaplan,¹ G. Gaesser,² R. Heilman,¹ H. Khamash,¹ K. Reddy,¹ E. Steidley,¹ A. Mathur,¹ S. Nair,¹ G. Mour,¹ J. Huskey,¹ A. Moss,¹ A. Singer,¹ W. Hewitt,¹ I. Qaqish,¹ S. Behmen,¹ S. Angadi.²

Concurrent Session: Kidney Clinical Complications 2  •  E354b